Lack of reproducibility in drug discovery has thrown the industry into crisis, scientists from Molecule and Arctoris claim, and suggest their discovery platform answers this challenge.
The lack of an Ebola vaccine decades after the virus was discovered is due in part to IP protections in trade deals like TTIP that discourage innovation according to NGO, Health Action International (HAI).
The global CMO market will grow from $26bn in 2010 to $59.9bn by 2018 thanks to a boom in the amount of work outsourced to the Asia market, says GBI Research.
Unilife saw its losses increase in the second quarter of fiscal 2011 on the lack of industrialisation revenue, higher R&D spending and the cost of its move to the US.
India and Thailand have requested the WHO ends its involvement with IMPACT, which the countries believe has conflicts of interest, and begin a programme focused on quality, safety and efficacy.
The WHO has delayed its controversial EB 124/14 amendment that would, according to some groups, broaden the organisation’s definition of “counterfeit” from its current focus on patient health to include infringements of intellectual property.
US President George W Bush has signed a bill under which counterfeiters can be sentenced to life imprisonment if their crime causes the death of an individual.
The rapidly growing market for drug discovery outsourcing services
will increase 15 per cent to reach $7bn (€5.5bn) by 2009, fuelled
by the advancing Asian market, according to a new study by Kalorama
Information, publishing division...
Asia and India are continuing to attract a wave of foreign
outsourcing contracts in the pharma industry, as companies are
lured by productivity-and cost savings. However, these countries
are not yet reaching their potential, as fears...
The European Commission has profiled the top 100 biotech technology
offers in a new brochure, which showcases the offers in such a way
that encourages European researchers to pursue the exploitation of
their own research results.
After a two-year tug-of-war, the World Trade Organization (WTO) has
solidified a landmark agreement to allow poor nations to import
generic versions of patented drugs to treat serious diseases or
epidemics.
In the first of a two-part interview, DrugResearcher.com
took time out to talk to Dr. Tim Jaeger, director of business
development at iAS interactive Systems, Germany. Speaking at the
recent Drug Discovery Technology Europe conference...
Pharming, a Dutch company specialising in the production of
proteins from transgenic animals, has acquired an Australian
company to shore up its patent position and technology portfolio in
this area.
Invitrogen announced that it has obtained the licensed rights for
the development of protein microrrays, which contain more than 200
protein-based analytes, further increasing its intellectual
property position in the burgeoning microarray...
China has defended its decision to overturn Pfizer's patent on its
blockbuster drug for erectile dysfunction, Viagra (sildenafil), in
a ruling that was seen as a blow to hopes that the country would
enforce intellectual property...
Much has been written on In-Pharmatechnologist.com about the
impact on China of accession to the World Trade Organisation and
the effects on the domestic pharmaceutical industry of the
resulting need to comply with international intellectual...